Rosuvastatin May Reduce the Incidence of Cardiovascular Events in Patients with Acute Coronary Syndromes Receiving Percutaneous Coronary Intervention by Suppressing miR-155/SHIP-1 Signaling Pathway
Xie, Wenchao, Li, Ping, Wang, Zhengdong, Chen, Jian, Lin, Zhihai, Liang, Xiangwen, Mo, YingxiVolume:
32
Language:
english
Journal:
Cardiovascular Therapeutics
DOI:
10.1111/1755-5922.12098
Date:
December, 2014
File:
PDF, 428 KB
english, 2014